Evaluation and comparison of efficacy and in use skin safety of Clobetasol gel (Clobetasol Propionate USP 0.05% w/w) and Clobetasol Cream (Clobetasol Propionate BP 0.05% w/w) in patients with mild to moderate psoriasis

Curatio Healthcare Pvt Ltd0 个研究点目标入组 28 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Voluntary men/women with clinically diagnosed mild to moderate stable, chronic, plaque psoriasis.
•2. 2.At least one, discrete, well circumscribed lesion approximately 20 cm2 â?? 80 cm2 on trunk separated from adjacent lesions by at least 3 cms.The same lesion will be tracked through the entire study.
•3.Age between 18 â?? 55 years
•4.Not on treatment for psoriasis- oral since 1 month and topical since 2 weeks.
•5.Accepting not to use products with the same end benefit during the entire study duration.
•6.Cooperating, informed of the need and duration of the examinations, and ready to comply with protocol procedures.
•7.Having signed a Consent Form and will be informed orally and in writing of all information concerning the study procedures and study objectives.

•1.Pustular psoriasis, Palmoplanter and erythrodermic psoriasis.
•2.Pregnant women (as confirmed by UPT) and lactating women.
•3.History of allergic dermatitis or contact allergy to cosmetics,
•4.Hypersensitivity to any cosmetic product, raw material.
•5.For whom the Investigator considers that he/she will not be compliant with study procedures.
•6.Any clinically significant systemic or cutaneous disease, which may interfere with study treatments or procedures.
•7.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month).
•8.Subject in an exclusion period or participating in another similar cosmetic or therapeutic trial.

发起方

Curatio Healthcare Pvt Ltd